{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T22:10:17Z","timestamp":1712268617843},"reference-count":24,"publisher":"EDP Sciences","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1051\/medsci\/200319101011","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T22:03:28Z","timestamp":1299362608000},"page":"1011-1015","source":"Crossref","is-referenced-by-count":2,"title":["Sant\u00e9 publique : le contr\u00f4le des maladies m\u00e9ningococciques au Qu\u00e9bec"],"prefix":"10.1051","volume":"19","author":[{"given":"Philippe","family":"De Wals","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Duval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Boulianne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"250","published-online":{"date-parts":[[2003,10,15]]},"reference":[{"key":"R1","unstructured":"Sakett DL, Richardson WS, Rosenberg W, Haynes RB.Evidence-based medicine. How to practice and teach EBM. New York : Churchill Livingstone, 1997 : 250 p."},{"key":"R2","unstructured":"Varughese PV, Carter AO. Meningococcal disease in Canada. Surveillance summary to 1987.Can Dis Wkly Rep1989; 15 : 89\u201396."},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Ashton FE, Ryan JA, Borczyk A, Caugant DA, Mancino L, Huang D. Emergence of a virulent clone ofNeisseria meningitidisserotype 2a that is associated with meningococcal group C disease in Canada.J Clin Microbiol1991; 29 : 2489\u201393.","DOI":"10.1128\/JCM.29.11.2489-2493.1991"},{"key":"R4","unstructured":"Lavigne P, Boulianne N, Fortin C, Naccache H, Douville-Fradet M. Meningococcal infections in Quebec, 1991-1992.Can Commun Dis Rep1992; 18 : 113\u20136."},{"key":"R5","unstructured":"Frasch CE. Meningococcal vaccines : Past, present and future. In : Cartwright K, ed.Meningococcal disease. Chichester : John Wiley and Sons, 1995 : 245\u201383."},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Taunay AE, Feldman RA, Bastos CO, Galvao PAA, Morais JS, Castro IO. Avalia\u00e7\u00e3o do efeito protector de vacina polissacaridica antimenigococica da grupo C, em crian\u00e7as de 6 a 36 meses.Rev Inst Adolfo Lutz1978; 32 : 77\u201382.","DOI":"10.53393\/rial.1978.38.37124"},{"key":"R7","unstructured":"Direction de la protection de la sant\u00e9 publique. Bilan de la campagne de vaccination contre les infections \u00e0 m\u00e9ningocoques. D\u00e9cembre 1991 \u00e0 avril 1993. Version initiale. Qu\u00e9bec: Minist\u00e8re de la Sant\u00e9 et des Services sociaux, 1994 : 176 p."},{"key":"R8","unstructured":"De Wals P, Dionne M, Douville-Fradet M, Boulianne N, Drapeau J, De Serres G. Impact of a mass immunization campaign against serogroup C meningococcus in the province of Quebec, Canada.Bull WHO1996; 74 : 407\u201311."},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Rivest P, Sagot B, B\u00e9dard L. Evaluation of the completeness of reporting of invasive meningococcal disease.Can J Publ Health1999; 90 : 250\u20132.","DOI":"10.1007\/BF03404126"},{"key":"R10","unstructured":"Yergeau A, Alain L, Pless Ret al.Adverse events temporally associated with meningococcal vaccines.Can Med Assoc J1996; 154 : 503\u20137."},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Erickson L, De Wals P. Complications and sequelae of meningococcal disease in Quebec (Canada) 1990-1994.Clin Infect Dis1998; 26 : 1159\u201364.","DOI":"10.1086\/520303"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Lebel MH, Tapiero BF, Saintonge F. Immunogenicity of bivalent AC polysaccharide meningococcal vaccine in children aged 6 through 24 months.JAMA2001; 285 : 1578\u20139.","DOI":"10.1001\/jama.285.12.1578"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"De Wals P, De Serres G, Niyonsenga T. Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec.JAMA2001; 285 : 177\u201381.","DOI":"10.1001\/jama.285.2.177"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"De Wals P, Erickson L. Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec.Vaccine2002; 20 : 2840\u20134.","DOI":"10.1016\/S0264-410X(02)00161-5"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Hubert B, Caugant DA. Recent changes in meningococcal disease in Europe. Eurosurveillance 1997; 10 : 1\u20134. (http:\/\/www.ceses.org\/euro surv\/v2n10\/en15-221.htm).","DOI":"10.2807\/esm.02.10.00145-en"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Stein KE. Thymus-independent and thymus-dependent responses to polysaccharide antigens.J Infect Dis1992; 165 (suppl 1) : S49\u201352.","DOI":"10.1093\/infdis\/165-Supplement_1-S49"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Pollard AJ, Maiden MCJ.Meningococcal vaccines. Methods and protocols. Totowa, New Jersey : Humana Press, 2001 : 422 p.","DOI":"10.1385\/1592591485"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Miller E, Salisbury D, Ramsay M. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK : a success story.Vaccine2002; 20 : S58\u201367.","DOI":"10.1016\/S0264-410X(01)00299-7"},{"key":"R19","unstructured":"Delbecq AL, Van de Ven AH, Gustafson DH.Group techniques for program planning : A guide to nominal group and Delphi processes. Glenview, Illinois : Scott, Foresman and Company, 1975."},{"key":"R20","unstructured":"Comit\u00e9 sur l\u2019immunisation du Qu\u00e9bec. \u00c9valuation du co\u00fbt et des avantages potentiels d\u2019une campagne d\u2019immunisation contre le m\u00e9ningocoque de s\u00e9rogroupe C au Qu\u00e9bec. Qu\u00e9bec: Institut de sant\u00e9 publique du Qu\u00e9bec, 2001 : 1\u201320. (http:\/\/www.inspq.qc.ca)."},{"key":"R21","unstructured":"De Wals P, Allard MA, Guindon K, Mayrand L, Simard S, Black R. La vaccination contre le m\u00e9ningocoque est-elle utile ? R\u00e9sultats d\u2019une enqu\u00eate dans la r\u00e9gion de Sherbrooke.Can Commun Dis Rep2002; 28 : 61\u20133."},{"key":"R22","unstructured":"Comit\u00e9 sur l\u2019immunisation du Qu\u00e9bec. Pertinence de l\u2019introduction du vaccin m\u00e9ningococcique dans le calendrier r\u00e9gulier d\u2019immunisation au Qu\u00e9bec. Qu\u00e9bec: Institut de sant\u00e9 publique du Qu\u00e9bec, 2002 : 1\u201316. (http:\/\/www.inspq.qc.ca)."},{"key":"R23","unstructured":"Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to warrant adoption and utilization ? Tentative guidelines for using clinical and economic evaluations.Can Med Assoc J1992; 146 : 473\u201381."},{"key":"R24","unstructured":"Erickson LJ, De Wals P, Farand L. Equitable access to vaccination : Immunization program planning in Canada. Report presented to the Division of Immunization, Health Canada, Ottawa, May 22, 2001."}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/200319101011\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T21:06:08Z","timestamp":1712264768000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/200319101011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":24,"journal-issue":{"issue":"10"},"alternative-id":["medsci20031910p1011"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/200319101011","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}